caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1831108323

Akiko SuzukiM.D.

Internal MedicineTorrance, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Akiko Suzuki's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 12 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
TORRANCE MEMORIAL MEDICAL CENTER56183
KURATA, FRED3794
Lucas Nishioka
Diagnostic Radiology · Torrance, CA
2859
HUETTNER, GLENN2867
Thomas Togioka
Cardiology · El Segundo, CA
2485
Haruo Arita
Anesthesiology · Torrance, CA
23100
Unilab Corporation
Clinical Laboratory · West Hills, CA
1959
Janak Raval
Diagnostic Radiology · Torrance, CA
1936
Richard Sullivan
Diagnostic Radiology · Torrance, CA
1741
Michael Stein
Diagnostic Radiology · Torrance, CA
1728
Masaharu Osato
Gastroenterology · Torrance, CA
1540
Dan Sakamoto
Ophthalmology · Torrance, CA
1431
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,630
Unique beneficiaries
—
Total services
2,725
Distinct HCPCS
15
Medicare payment
$202K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).
PRESCRIBING · PART D · 2024
Total Rx claims
3,937
Beneficiaries
—
Total drug cost
$92K
Distinct drugs
58
Brand share
9.2%
Top prescribed drugs
Atorvastatin Calcium443 claims
Alendronate Sodium400 claims
Losartan Potassium343 claims
Amlodipine Besylate309 claims
Levothyroxine Sodium208 claims
QUALITY · MIPS · 2024
Final MIPS score
99.9
Quality
99.8
Cost
94.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$76
Payment records
2
By payment type
Food and Beverage$76